Showing results (4081-4090 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|June 30, 2025
Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumorsYu Jiang, Xu Liang, Mei-Li Sun, et al.The Oncologist|July 1, 2025
Impact of Molecular Tumor Board on Clinical Outcomes in Patients with Refractory Solid Tumor: a Real-World StudyYan Ling, Xiao-Dong Jiao, Bao-Dong Qin, et al.The Oncologist|July 1, 2025
Prognostic index for predicting outcomes of trastuzumab deruxtecan in HER2 expressing metastatic breast cancer: a real-world multicenter studyCong Xue, Qianyi Liao, Riqing Huang, et al.The Oncologist|July 1, 2025
The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: desensitization therapy and pharmacogenetic investigationXiaoman Liu, Mengying Pi, Mukai Chen, et al.The Oncologist|June 24, 2025
Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic reviewJun Yang Jiang, Ang Li, Alexis Romero, et al.The Oncologist|September 8, 2025
The safety profile of belzutifan in renal tumors: real-world data from a tertiary academic centerAaron Jacob Winer, Paulo Siqueira do Amaral, Elizabeth G Ryan, et al.The Oncologist|September 19, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancerB J Rimel, Eric Pujade-Lauraine, Kathleen Moore, et al.The Oncologist|September 19, 2025
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinomaJorien B E Janssen, Kirti K Iyer, Sophie L Gerritse, et al.The Oncologist|September 20, 2025
Factors associated with sleep disturbance in breast cancer survivors over timePaulina S Marell, Robert A Vierkant, Nicole L Larson, et al.The Oncologist|June 14, 2025
A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterationsMargaret C Wheless, Tyler J Zemla, Joleen M Hubbard, et al.Pageof 571